ℹ️ Compiled from public regulatory records · Last regulator revision: October 31, 2025🚩 Report this page
Vanzacaftor
Active ingredient
Sold as ALYFTREK
CA Health Canada
- Drug class
- -
- Availability
- See label
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 2
Overview
Vanzacaftor is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 2 | October 31, 2025 |
CACanada· Health Canada
2 products
2 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Brands in Canada (1)
Sources & citations
- [1]Health Canada (DPD) · 02559676 · revised October 31, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.